SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference
13 sept. 2024 07h00 HE
|
SAB Biotherapeutics, Inc.
MIAMI, Sept. 13, 2024 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human...
DXCM INVESTOR DEADLINE: DexCom, Inc. Investors that Lost Money are Reminded to Contact BFA Law by October 21 Court Deadline in Class Action Lawsuit (Nasdaq:DXCM)
13 sept. 2024 06h37 HE
|
Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
DXCM LAWSUIT NEWS: A Class Action Lawsuit has been Filed Against DexCom, Inc. for Securities Fraud; Contact BFA Law before October 21 Legal Deadline (Nasdaq:DXCM)
11 sept. 2024 06h31 HE
|
Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
DXCM FRAUD ALERT: DexCom, Inc. has been Sued for Securities Fraud – Contact BFA Law by October 21 if You Suffered Losses on Your Investment (Nasdaq:DXCM)
09 sept. 2024 15h33 HE
|
Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
World-renowned diabetes researcher joins Wendy Novak Diabetes Institute
09 sept. 2024 10h30 HE
|
Norton Healthcare
LOUISVILLE, Ky., Sept. 09, 2024 (GLOBE NEWSWIRE) -- An internationally known researcher is joining Wendy Novak Diabetes Institute, a part of Norton Healthcare and Norton Children’s, with the goal of...
DXCM DEADLINE REMINDER: DexCom, Inc. Investors who Lost Money are Reminded to Contact BFA Law before Upcoming Securities Litigation Deadline (Nasdaq:DXCM)
07 sept. 2024 07h16 HE
|
Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
Digital Marketing Trends in Type 2 Diabetes
03 sept. 2024 10h45 HE
|
Research and Markets
Dublin, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The "Digital Marketing Trends in Type 2 Diabetes - April 2024" report has been added to ResearchAndMarkets.com's offering. This report provides an...
Fractyl Health to Participate in Upcoming September Investor Conferences
03 sept. 2024 07h00 HE
|
Fractyl Health, Inc.
Fractyl Health to Participate in Upcoming September Investor Conferences
DXCM STOCK NOTICE: DexCom, Inc. is being Sued for Securities Fraud; Contact BFA Law Now about the Lawsuit if You Lost Money on Your Investment (Nasdaq:DXCM)
03 sept. 2024 06h36 HE
|
Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
03 sept. 2024 06h30 HE
|
Embecta Corp.
embecta has received 510(k) clearance from the FDA for its proprietary disposable insulin delivery system, a patch pump with a 300-unit insulin reservoir.